Evidence map›Paper›PMID 36017587›Full record

ArticleThe Journal of clinical endocrinology and metabolism2022

Inflammatory Cytokines Rewire the Proinsulin Interaction Network in Human Islets.

Duc T Tran, Anita Pottekat, Kouta Lee, Megha Raghunathan, Salvatore Loguercio, Saiful A Mir, Adrienne W Paton, James C Paton, Peter Arvan, Randal J Kaufman and 1 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Coordinated expression and assembly of BiP, p58Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Inflammatory Cytokines Rewire the Proinsulin Interaction Network in Human Islets.The Journal of clinical endocrinology and metabolism · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Duc T TranSanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Anita PottekatSanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.ORCID 0000-0002-2117-6887
Kouta LeeSanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Megha RaghunathanSanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.ORCID 0000-0002-9330-7639
Salvatore LoguercioScripps Research Institute, La Jolla, CA, USA.ORCID 0000-0002-7544-2992
Saiful A MirSanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.ORCID 0000-0003-1179-3774
Adrienne W PatonThe University of Adelaide, Adelaide, Australia.ORCID 0000-0002-2996-5733
James C PatonThe University of Adelaide, Adelaide, Australia.
Peter ArvanUniversity of Michigan Medical School, Ann Arbor, MI, USA.ORCID 0000-0002-4007-8799
Randal J KaufmanSanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.ORCID 0000-0003-4277-316X
Pamela Itkin-AnsariSanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.ORCID 0000-0002-8759-3034
Sanford Burnham Prebys Medical Discovery Institute · USThe University of Adelaide · AUIllumina (United States) · USScripps Research Institute · USUniversity of Calcutta · INUniversity of Michigan · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Proinsulin Trafficking for Insulin BiosynthesisR01DK048280 · NIDDK · YESHIVA UNIVERSITY · PI ARVAN, PETER · 1994 to 2024
$10.5M
Modifiers of Proinsulin Influence T2D SusceptibilityR24DK110973 · NIDDK · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI ARVAN, PETER, ITKIN-ANSARI, PAMELA ROSE · 2016 to 2019
$4.1M
Breakthrough T1D 2-SRA-2015-47-M-RNIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK048280NIDDK NIH HHS R24 DK110973NIH HHS R24 DK110973-01
6 · The paper itself

Abstract

contextAberrant biosynthesis and secretion of the insulin precursor proinsulin occurs in both type I and type II diabetes. Inflammatory cytokines are implicated in pancreatic islet stress and dysfunction in both forms of diabetes, but the mechanisms remain unclear.

objectiveWe sought to determine the effect of the diabetes-associated cytokines on proinsulin folding, trafficking, secretion, and β-cell function.

methodsHuman islets were treated with interleukin-1β and interferon-γ for 48 hours, followed by analysis of interleukin-6, nitrite, proinsulin and insulin release, RNA sequencing, and unbiased profiling of the proinsulin interactome by affinity purification-mass spectrometry.

resultsCytokine treatment induced secretion of interleukin-6, nitrites, and insulin, as well as aberrant release of proinsulin. RNA sequencing showed that cytokines upregulated genes involved in endoplasmic reticulum stress, and, consistent with this, affinity purification-mass spectrometry revealed cytokine induced proinsulin binding to multiple endoplasmic reticulum chaperones and oxidoreductases. Moreover, increased binding to the chaperone immunoglobulin binding protein was required to maintain proper proinsulin folding in the inflammatory environment. Cytokines also regulated novel interactions between proinsulin and type 1 and type 2 diabetes genome-wide association studies candidate proteins not previously known to interact with proinsulin (eg, Ataxin-2). Finally, cytokines induced proinsulin interactions with a cluster of microtubule motor proteins and chemical destabilization of microtubules with Nocodazole exacerbated cytokine induced proinsulin secretion.

conclusionTogether, the data shed new light on mechanisms by which diabetes-associated cytokines dysregulate β-cell function. For the first time, we show that even short-term exposure to an inflammatory environment reshapes proinsulin interactions with critical chaperones and regulators of the secretory pathway.

Indexed as

Diabetes Mellitus, Type 2Insulin-Secreting CellsIslets of LangerhansCytokinesGenome-Wide Association StudyHumansInsulinInterleukin-6ProinsulinCytokinesInsulinInterleukin-6Proinsulincytokineshuman isletsproinsulinprotein interactometype 1 diabetestype 2 diabetes

Identifiers

PMID36017587
PMCPMC10233482
OpenAlexW4293206643

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.